Protein, Heart Health, and Food Ethics: Lab Notes, June 10

A landmark clinical trial reveals that evolocumab, a PCSK9 inhibitor, significantly reduces the risk of first major cardiovascular events in high-risk patients who’ve never had a heart attack or stroke. The study focused on adults with atherosclerosis or diabetes and LDL cholesterol levels of at least 90 mg/dL—individuals at elevated but not yet catastrophic risk.

Over a median follow-up of 4.6 years, monthly subcutaneous evolocumab (140 mg every two weeks) reduced the risk of death from coronary heart disease, myocardial infarction, or ischemic stroke by 25%, with a hazard ratio of 0.75. This translates to a 5-year event risk dropping from 8.0% to 6.2%, meaning just 56 patients need to be treated to prevent one major event.

Importantly, evolocumab did not increase serious adverse events compared to placebo, supporting its safety for long-term use. The benefit was consistent across revascularization procedures as well, reducing the broader 4-point MACE endpoint by 19%.

While the trial population was predominantly White (93%) and middle-aged or older (median age 66), the results suggest a powerful preventive tool for a growing segment of the population managing metabolic and vascular risk.

A new 8-week clinical trial investigates whether increasing protein intake enhances weight loss and fullness during a low-energy diet in women with obesity. The study compared high-protein versus standard-protein diets, both within a partial meal-replacement framework, to isolate the effects of macronutrient composition.

Results showed that a higher protein diet significantly improved satiety and reduced hunger, supporting the idea that protein helps control appetite. However, this did not consistently translate into greater weight loss compared to lower-protein, low-energy diets—suggesting that total calorie deficit remains the dominant factor.

The study also found that the benefits of increased protein were independent of carbohydrate content, meaning the satiety effect wasn’t tied to low-carb eating. This is important for those seeking flexible, sustainable diet strategies.

While protein clearly plays a role in appetite regulation, the findings caution against overestimating its impact on fat loss. The real power may lie in adherence: feeling fuller could help people stick to their diets longer.

Could a combination of leucine supplements and sprint exercise help regulate appetite in people with overweight? A new randomized crossover study tested this idea in sedentary men, measuring hunger, food intake, and inflammation after acute doses of L-leucine and high-intensity sprints.

Surprisingly, L-leucine alone increased appetite in some participants, contrary to expectations that branched-chain amino acids suppress hunger. Meanwhile, sprint exercise reduced appetite as expected—but when combined with leucine, the effects were inconsistent, with no clear synergistic benefit.

The study also found distinct inflammatory responses: sprinting triggered a temporary anti-inflammatory signal, while leucine had mixed effects on cytokine levels. This suggests that while exercise remains a reliable tool for appetite and metabolic health, amino acid supplements may not be a straightforward add-on.

For now, the data caution against relying on leucine supplements for weight management. Natural protein sources may offer a more balanced physiological response.

Vital Farms, a brand known for its pasture-raised eggs and ethical marketing, is facing intensified scrutiny after new allegations surfaced about animal welfare and labeling practices. A viral video titled No Seriously, The Vital Farms Scandal Just Got Worse... has reignited consumer skepticism, amassing strong engagement with a Pro-to-Against score of 24.0 to 8.0.

While no formal study or audit is cited, the video presents undercover footage and whistleblower accounts suggesting that some farms in the Vital Farms network may not meet the company’s claimed standards for outdoor access and hen treatment. Critics argue that the brand’s premium pricing relies heavily on trust in its ethical claims.

The controversy highlights a growing tension in the food industry: as demand for humane and sustainable products rises, so does the risk of 'ethical washing.' Consumers are increasingly demanding transparency, third-party verification, and stricter oversight.

For fitness and nutrition enthusiasts who prioritize clean, ethical food sources, this serves as a reminder to look beyond branding and seek verifiable certifications.

A popular YouTube video titled This New Protein Study just Changed how we Think about Protein! is making waves, claiming to overturn conventional wisdom about protein intake. With a Pro-to-Against score of 36.0 to 17.0, it’s resonating with viewers—but lacks a clear summary or cited study.

While the video appears to reference emerging research on protein metabolism, timing, or sources, the absence of specific data makes it difficult to validate its claims. This reflects a broader issue in fitness media: bold headlines often outpace scientific clarity.

That said, the high engagement suggests public appetite for updated protein guidance—especially around optimal intake, plant vs. animal sources, and effects on aging and metabolism.

Until more details emerge, it’s wise to rely on established evidence: total daily protein (1.6–2.2 g/kg for active individuals), even distribution across meals, and whole-food sources remain the gold standard.